Literature DB >> 15679669

Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.

R Fotedar1, S S A Al-Hedaithy.   

Abstract

Although the production of virulence enzymes by Candida albicans has been extensively explored, little attention has been given to the virulence factors of C. dubliniensis. In the present study, an attempt was made to investigate phospholipase activity (Pz value) and secretory aspartyl proteinase production of C. dubliniensis and compare it with C. albicans. None of the 87 C. dubliniensis isolates tested, produced phosholipases whereas, in contrast all the 52 (100%) C. albicans isolates tested demonstrated varying degree of phospholipase activity (Pz value: 0.37-0.74), with 35 (67.3%) of them eliciting a higher phospholipase activity (Pz values between 0.37 and 0.50). Only 32% of the C. dubliniensis isolates exhibited moderate activity (score of 1+) of secretory aspartyl proteinase whereas a vast majority (68%) of them were non-proteolytic. On the contrary, a strong proteinase activity (score of 2+) was observed for 79% of C. albicans while the remaining 21% isolates showed moderate proteinase activity (score of 1+). As phospholipases and aspartyl proteinases of C. albicans are considered important virulence factors, the absence or lowered expression of these enzymes in C. dubliniensis may indicate the less virulent nature of this novel yeast species when compared with C. albicans.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15679669     DOI: 10.1111/j.1439-0507.2004.01057.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  10 in total

1.  Species distribution and antifungal susceptibility profile of oral candida isolates from HIV-infected patients in the antiretroviral therapy era.

Authors:  Carolina Rodrigues Costa; Janine Aquino de Lemos; Xisto Sena Passos; Crystiane Rodrigues de Araújo; Ana Joaquina Cohen; Lúcia Kioko Hasimoto E Souza; Maria do Rosário Rodrigues Silva
Journal:  Mycopathologia       Date:  2006-07       Impact factor: 2.574

Review 2.  Potential Targets for Antifungal Drug Discovery Based on Growth and Virulence in Candida albicans.

Authors:  Xiuyun Li; Yinglong Hou; Longtao Yue; Shuyuan Liu; Juan Du; Shujuan Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-07-20       Impact factor: 5.191

3.  Differential resistance to oxidants and production of hydrolytic enzymes in Candida albicans.

Authors:  Maxwel A Abegg; Rodrigo Lucietto; Paulo V G Alabarse; Marcus F A Mendes; Mara Silveira Benfato
Journal:  Mycopathologia       Date:  2010-07-15       Impact factor: 2.574

4.  Upregulation of secreted aspartyl proteinase genes of fluconazole-sensitive Candida albicans isolates.

Authors:  Carolina do Rosário Esteves Guimarães; Humberto Fonseca de Freitas; Tânia Fraga Barros
Journal:  Mol Biol Rep       Date:  2019-10-10       Impact factor: 2.316

Review 5.  Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis.

Authors:  Mohd Sajjad Ahmad Khan; Fatimah Alshehrei; Saleh Bakheet Al-Ghamdi; Majid Abdullah Bamaga; Abdullah Safar Al-Thubiani; Mohammad Zubair Alam
Journal:  Future Sci OA       Date:  2020-02-03

6.  Case Report: Candida dubliniensis as a Cause of Chronic Meningitis.

Authors:  Madiha Tahir; Andrew M Peseski; Stephen J Jordan
Journal:  Front Neurol       Date:  2020-12-08       Impact factor: 4.003

7.  Back to Nature: Combating Candida albicans Biofilm, Phospholipase and Hemolysin Using Plant Essential Oils.

Authors:  Ahmed M El-Baz; Rasha A Mosbah; Reham M Goda; Basem Mansour; Taranum Sultana; Tanya E S Dahms; Amira M El-Ganiny
Journal:  Antibiotics (Basel)       Date:  2021-01-15

8.  Candida albicans as an Essential "Keystone" Component within Polymicrobial Oral Biofilm Models?

Authors:  Tracy Young; Om-Alkhir Alshanta; Ryan Kean; David Bradshaw; Jonathan Pratten; Craig Williams; Chris Woodall; Gordon Ramage; Jason L Brown
Journal:  Microorganisms       Date:  2020-12-28

9.  ABC typing and extracellular enzyme production of Candida albicans isolated from Candida vulvovaginitis.

Authors:  Maral Gharaghani; Mahbubeh Shabanzadeh; Hadis Jafarian; Ali Zarei Mahmoudabadi
Journal:  J Clin Lab Anal       Date:  2021-11-27       Impact factor: 2.352

10.  Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Pol J Microbiol       Date:  2020-03-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.